Add to ORKG[[sponsorship]]細胞與個體生物學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1078-0432&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00016931060000
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...
More than 2 million new cases of breast cancer (BC) are registered annually. BC is the most common m...
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...
Overexpression of the c-erbB-2 (HER-2/neu) oncogene, which encodes a transmembrane receptor tyrosine...
The aim of this study was to evaluate the role of several biological and histological markers (topoi...
Purpose: Topoisomerase IIα (Topo II) is a potential marker of responsiveness to anthracycline-based ...
Purpose: The predictive value of topoisomerase-II? (topo-II) has been evaluated in advanced breast c...
Purpose: The predictive value of topoisomerase-IIalpha (topo-II) has been evaluated in advanced brea...
Topoisomerase-IIalpha (topo-II) is a molecular target for topo-II inhibitors, which makes it a poten...
Recent clinical trials have suggested that patients whose breast tumors overexpress HER2 may derive ...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
The aim of this study was to evaluate the association between immunohistochemical expression of topo...
BackgroundTopoisomerase I (TOPO1) and topoisomerase IIα (TOP2A) are specific targets of multiple che...
AbstractWe identified the ubiquitin-conjugating enzyme E2EPF mRNA as differentially expressed in bre...
Primary objective. To investigate the relationship between human epidermal growth factor receptor (H...
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...
More than 2 million new cases of breast cancer (BC) are registered annually. BC is the most common m...
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...
Overexpression of the c-erbB-2 (HER-2/neu) oncogene, which encodes a transmembrane receptor tyrosine...
The aim of this study was to evaluate the role of several biological and histological markers (topoi...
Purpose: Topoisomerase IIα (Topo II) is a potential marker of responsiveness to anthracycline-based ...
Purpose: The predictive value of topoisomerase-II? (topo-II) has been evaluated in advanced breast c...
Purpose: The predictive value of topoisomerase-IIalpha (topo-II) has been evaluated in advanced brea...
Topoisomerase-IIalpha (topo-II) is a molecular target for topo-II inhibitors, which makes it a poten...
Recent clinical trials have suggested that patients whose breast tumors overexpress HER2 may derive ...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
The aim of this study was to evaluate the association between immunohistochemical expression of topo...
BackgroundTopoisomerase I (TOPO1) and topoisomerase IIα (TOP2A) are specific targets of multiple che...
AbstractWe identified the ubiquitin-conjugating enzyme E2EPF mRNA as differentially expressed in bre...
Primary objective. To investigate the relationship between human epidermal growth factor receptor (H...
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...
More than 2 million new cases of breast cancer (BC) are registered annually. BC is the most common m...
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up...